Latest News Archive

Please select Category, Year, and then Month to display items
Categories
UFS News Media Release Research
Years
2017 2018 2019 2020 2021 2022 2023 2024
Months
January February March April May June July August September October November December
Previous Archive
27 August 2018 Photo Barend Nagel
WomenOfKovsies Arina Engelbrecht advocates healthy living nationally
Arina Engelbrecht’s vision is for all Kovsies to lead holistically healthy lives.

How do you start living a healthy lifestyle? Arina Engelbrecht, a wellness specialist in the Employee Wellness Division at the University of the Free State (UFS) says it only takes a few changes. Her passion is to motivate people to live a balanced life.  

Being active enables a person to live life to the full. “Aim to exercise 150 minutes a week, which equates to 30 minutes five times a week in order to experience health benefits like prevention of lifestyle illnesses, better sleeping patterns, decreasing stress or anxiety and feeling more energetic,” says Engelbrecht.

Some of the initiatives Engelbrecht and her team drive are the Healthy Lifestyle Challenge, Park Runs in Bloemfontein, and the Healthy4Life Pedometer Challenge, which encourage staff members to become more physically active. “Everything we do, think or feel is influenced by what we eat! It is therefore important to eat a balanced diet. Healthy food = quality fuel = good health = sustained energy = peak performance,” she explains. 
 
Pedometer Challenge

In the space of eight weeks 240 staff members from all campuses walked 54 000km as part of the Pedometer Challenge. Engelbrecht and her team mobilised 53 active teams from all three campuses. Three of these teams emerged as the winners as they exceeded the target of 1 300km which is the equivalent of walking to Cape Town. In September 2018 the Challenge is going national as the North-West University competes against UFS.

Celebrating women

This Women’s Month Engelbrecht’s message to women of Kovsies is: “We must start embracing who we are and start believing in ourselves, whether it is in the workplace, in business, or at home.” 

News Archive

Researchers receive study grant for research into Congo Fever
2015-03-10

UFS researchers will be contributing significantly to the search for a vaccine against the deadly tick-borne disease known as Congo Fever.

Prof Felicity Burt from the Department of Medical Microbiology and Virology was recently awarded a research grant by the National Health Laboratory Service (NHLS) to study candidate vaccines for Crimean-Congo heamorrhagic fever (CCHF) virus and other arboviruses.

Arboviruses are viruses transmitted by mosquitoes, ticks, or other arthropods.

Prof Burt is an internationally-recognised expert on the Crimean-Congo haemorrhagic fever (CCHF). The Crimean-Congo haemorrhagic fever (CCHF) virus is a tick-borne virus that is associated with severe haemorrhagic disease in South Africa and other parts of Africa, Asia, and eastern Europe. Her interests focus on medically significant viruses that are transmitted by ticks and mosquitoes. Her research group is involved in determining the immune responses that are induced by different viral proteins.

Crimean-Congo haemorrhagic fever (CCHF) virus, a tick- borne virus found in Africa, Asia, the Balkans, and eastern Europe, causes severe viral haemorrhagic fever outbreaks.

Although a number of tick species are capable of becoming infected with CCHF virus, ticks of the genus Hyalomma, commonly referred to in SA as the “bont-legged ticks”, are the principal vector. The ticks have distinctive brown and white bands on their legs.

In February 1981, the first case of CCHF was recognised in South Africa (SA). To date, there have been nearly 200 cases of CCHF infection in SA with a 20% fatality rate. The majority of cases occurring in SA were in patients from the Northern Cape and Free State provinces.

“The funding that has been awarded will be used to profile immune responses against CCHF viral proteins, and investigate mechanisms and strategies to enhance these immune responses. We hope that the study will contribute knowledge towards the development of a vaccine against this medically significant virus.”

For more information or enquiries contact news@ufs.ac.za.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept